Fumihiro Tomoda
Overview
Explore the profile of Fumihiro Tomoda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
64
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tomoda F, Koike T, Nitta A, Kurosaki H, Sugimori H, Oh-Hara M, et al.
J Hypertens
. 2023 Aug;
41(10):1571-1577.
PMID: 37642591
Objectives: The relationships between stress hormones and oxidative DNA damage have not yet been explored in human hypertension. We investigated the associations of urinary levels of cortisol or catecholamines with...
2.
Koike T, Imamura T, Tomoda F, Ohara M, Fujioka H, Kakeshita K, et al.
J Clin Med
. 2023 Jan;
12(2).
PMID: 36675499
Background: In patients with essential hypertension, a non-dipping blood pressure pattern is a strong risk factor for cardiovascular diseases. However, background factors associating with such a blood pressure pattern remain...
3.
Tomoda F, Nitta A, Sugimori H, Koike T, Kinugawa K
Int J Hypertens
. 2022 Mar;
2022:3003269.
PMID: 35284140
Nerve growth factor (NGF) is the main neurotrophic factor that can control sympathetic nerve innervation and sympathetic neural activity in cardiovascular organs. Although NGF overproduction and its influences on the...
4.
Fujioka H, Koike T, Imamura T, Tomoda F, Kakeshita K, Yamazaki H, et al.
Nutrients
. 2022 Feb;
14(4).
PMID: 35215451
The prognostic impact of the combination of a geriatric nutritional risk index (GRNI) and modified creatinine index, both of which assess nutritious status in hemodialysis patients, has not yet been...
5.
Mizushige T, Kobori H, Hitomi H, Nishijima Y, Tomoda F, Morimoto S, et al.
Int J Mol Sci
. 2016 Nov;
17(11).
PMID: 27801805
This study was performed to demonstrate urinary angiotensinogen as a potential prognostic marker of the albuminuria reduction effects of olmesartan in patients with metabolic syndrome. In 24 patients (eight women,...
6.
Ohara M, Tomoda F, Koike T, Liu H, Uno K, Nitta A, et al.
Clin Exp Pharmacol Physiol
. 2015 Apr;
42(6):687-94.
PMID: 25904086
To investigate the role of nerve growth factor (NGF) in the development of hypertensive renal vascular remodeling, antiserum against NGF (anti-NGF) or vehicle was injected at 3 weeks of age...
7.
Takiwaki M, Tomoda F, Koike T, Taki T, Inoue H, Kigawa M, et al.
Hypertens Res
. 2014 Jul;
37(11):1008-13.
PMID: 24990092
Among subfractions of low-density lipoprotein cholesterol (LDL-C), small dense LDL-C (SdLDL-C) has been highlighted as the most atherogenic lipoprotein cholesterol. The present study aimed to compare the relationship of SdLDL-C...
8.
Yamazaki H, Tomoda F, Koike T, Kinuno H, Sugimori H, Inoue H, et al.
Clin Exp Pharmacol Physiol
. 2014 Jan;
41(3):238-45.
PMID: 24471839
1. Renal vascular structural properties and their alterations by removal of uraemic toxins with AST-120, an oral adsorbent, were examined in subtotal nephrectomized rats. 2. Eight- or 9-week-old Sprague-Dawley rats...
9.
Hirose M, Tomoda F, Koike T, Yamazaki H, Ohara M, Liu H, et al.
Am J Hypertens
. 2013 Feb;
26(2):227-33.
PMID: 23382407
Background: In the kidney, 5-hydroxytryptamine (5-HT) and dopamine (DA) are formed by the same enzyme, l-aromatic amino acid decarboxylase, but act on renal function and glomerular structure in an opposite...
10.
Sugimori H, Tomoda F, Koike T, Kurosaki H, Masutani T, Ohara M, et al.
Hypertens Res
. 2012 Nov;
36(3):247-51.
PMID: 23154588
Increased blood viscosity reduces blood flow and elevates vascular resistance in the cardiovascular system. The aim of this study was to elucidate how blood viscosity could affect renal function and...